Statistics

Total Visits

Views
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia35

Select a period of time:

Number of views in the range

Views
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia10

Views

Views
September 20250
October 20250
November 20250
December 20251
January 20264
February 20263
March 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
Brazil1
Finland1
 

Top cities views

Views
San Jose2
Duque de Caxias1
Helsinki1